Design, synthesis and biological evaluation of phenylpicolinamide sorafenib derivatives as antitumor agents

Design, synthesis and biological evaluation of phenylpicolinamide sorafenib derivatives as antitumor agents
复制标题

抗肿瘤药物苯基吡啶酰胺索拉非尼衍生物的设计、合成及生物学评价

DOI:
10.1007/s00044-017-2045-0
复制
发表时间:
2018-02
影响因子:
2.6
通讯作者:
Zheng Pengwu
Zheng Pengwu
中科院分区:
医学4区
文献类型:
--
作者:
Wu Chunjiang;Xu Shan;Guo Yuping;Wu Jielian;Luo Rong;Wang Wenhui;Tu Yuanbiao;Chen Le;Zhu Wufu;Zheng Pengwu

文献摘要

参考文献

被引文献

相似文献

设计合成了两个系列的苯基吡啶甲酰胺索拉非尼衍生物(14a-k,15a-k)。评估了它们对三种癌细胞系(A549、Hela和MCF-7)以及VEGFR2/KDR、BRAF和CRAF激酶的IC50值。14个目标组合
Two series of phenylpicolinamide sorafenib derivatives (14a–k, 15a–k) were designed and synthesized. They were evaluated for IC50 values against three cancer cell lines (A549, Hela, and MCF-7) and VEGFR2/KDR, BRAF, and CRAF kinases. Fourteen target compou
DOI: 10.1158/0008-5472.can-04-1443
发表时间: 2004-10-01
期刊: CANCER RESEARCH
影响因子: 11.2
作者:
Wilhelm, SM;Carter, C;Trail, PA
通讯作者: Trail, PA
DOI: 10.1371/journal.pone.0025132
发表时间: 2011
期刊: PloS one
影响因子: 3.7
作者:
Roper J;Richardson MP;Wang WV;Richard LG;Chen W;Coffee EM;Sinnamon MJ;Lee L;Chen PC;Bronson RT;Martin ES;Hung KE
通讯作者: Hung KE
DOI: 10.1200/jco.2005.02.2574
发表时间: 2006-01-01
影响因子: 45.3
作者:
Motzer, RJ;Michaelson, MD;Rini, BI
通讯作者: Rini, BI
DOI: 10.1038/nrd2262
发表时间: 2007
影响因子: 120.1
作者:
S. Wilhelm;Christopher A. Carter;M. Lynch;T. Lowinger;J. Dumas;Roger A. Smith;B. Schwartz;R. Siman
通讯作者: S. Wilhelm;Christopher A. Carter;M. Lynch;T. Lowinger;J. Dumas;Roger A. Smith;B. Schwartz;R. Siman
DOI: 10.1021/jm800566m
发表时间: 2008-08-14
影响因子: 7.3
作者:
Harris, Philip A.;Boloor, Amogh;Stafford, Jeffrey A.
通讯作者: Stafford, Jeffrey A.